The Swiss TPH Summer Symposium 2018 invited clinical researchers, drug development specialists and students to review and discuss future approaches to drug development. Topics included:

  • Cost explosion of drug development
  • Impact of GCP-guideline amendment 2016
  • Conducting sponsor-investigator trials in Switzerland
  • Clinical trials in low resource settings
  • The Biotech approach to clinical development
  • The Pharma view on clinical development
  • Alternative business models and partnerships
{"locations":{"0":{"title":"Zentrum f\u00fcr Lehre und Forschung, UniSpital, Basel","description":"<p><span class=\"section-info-icon maps-sprite-pane-info-address\"> <\/span> <span class=\"section-info-text\">Hebelstrasse 30, 4056 Basel<\/span><\/p>","latitude":"47.5611824","longitude":"7.5799042,17","projects":{}}}}
Selected projects at this location:

Registration and Welcome
08.30    Registration
09:00    Welcome and Introduction, Christian Burri, Swiss TPH, Basel, Switzerland

Session 1 – Setting the Stage
Moderator: Daniel Paris, Swiss TPH, Basel, Switzerland
09:15    Cost of Development of Medicines for Neglected Diseases, Anna Doubell, Policy Cures Research, Sydney, Australia
09:45    Quality Framework for Clinical Trials, Matthias Briel, Clinical Trial Unit, Department of Clinical Research, University of Basel, Switzerland
10:15    Risk Management in Clinical Trials in Today’s ICH-GCP(R2) Framework, Ingrid Klingmann, European Forum for Good Clinical Practice, Brussels, Belgium  
10:45    Coffee Break

Session 2 – Clinical Research Worlds – Approaches and Challenges
Moderator: Wiweka Kaszubska, Medicines for Malaria Venture, Geneva, Switzerland
11:15    The Big Pharma Approach and Future Developments, Anthony Man, Novartis International AG, Basel, Switzerland
11:45    Conducting Investigator Initiated Trials in low Resource Settings – the Northern Perspective, Klaus Reither, Swiss TPH, Basel, Switzerland
12:15    Conducting Investigator Initiated Trials in low Resource Settings – the Southern Perspective, Ally Olotu, Ifakara Health Institute, Dar es Salaam, Tanzania
12:45    Lunch

Session 3 – Future Trends and Approaches
Moderator: Ingrid Klingmann, European Forum for Good Clinical Practice, Brussels, Belgium
14:00    Working in a PDP Business Model, David Reddy, Medicines for Malaria Venture, Geneva, Switzerland
14:30    The Future of Drug Development, Djordje Filipovic, Novartis International AG, Basel, Switzerland
15:00    Coffee Break

Session 4 – The Partnership Approach
Moderator: Christian Burri, Swiss TPH, Basel, Switzerland
15:30    Approaches, Success Stories and Challenges – the Industry Perspective, Luc Kuykens, Sanofi, France
16:00    Approaches, Success Stories and Challenges – the Academia Perspective, Christian Burri, Swiss TPH, Basel, Switzerland
16:30    Closing Words, Jürg Utzinger, Swiss TPH, Basel, Switzerland
17:00    Close of Day

Clinical Research in Resource Limited Settings - Mission Impossible or Role Model for Future Drug Development?

28 June 2018, Swiss TPH Summer Symposium
Zentrum für Lehre und Forschung, UniSpital, Basel, Switzerland